No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Zydus Receives Tentative Approval from FDA for Olaparib Tablets
On 7 November 2025, Medical Dialogues reported that Zydus Lifesciences has received tentative approval from the FDA for olaparib tablets, 100 mg and 150 mg, referencing AstraZeneca/MSD’s Lynparza®.